6 results on '"Victora, Gabriel D"'
Search Results
2. Slow Spread of SARS-CoV-2 in Southern Brazil Over a 6-Month Period: Report on 8 Sequential Statewide Serological Surveys Including 35 611 Participants.
- Author
-
Hallal, Pedro C., Silveira, Mariângela F., Menezes, Ana M. B., Horta, Bernardo L., Barros, Aluísio J. D., Pellanda, Lúcia C., Victora, Gabriel D., Dellagostin, Odir A., Struchiner, Claudio J., Burattini, Marcelo N., Mesenburg, Marilia A., Jacques, Nadege, Vidaletti, Luís Paulo, Ambros, Emanuele L., Berlezi, Evelise M., Schirmer, Helena, Renner, Jane D. P., Collares, Kaue, Ikeda, Maria Letícia R., and Ardenghi, Thiago M.
- Subjects
PUBLIC health surveillance ,COVID-19 ,CONFIDENCE intervals ,SERODIAGNOSIS ,POINT-of-care testing ,AGE distribution ,INFECTIOUS disease transmission ,DISEASE prevalence ,DESCRIPTIVE statistics ,STATISTICAL sampling ,VIRAL antibodies - Abstract
Objectives. To evaluate the spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) over 6 months in the Brazilian State of Rio Grande do Sul (population 11.3 million), based on 8 serological surveys. Methods. In each survey, 4151 participants in round 1 and 4460 participants in round 2 were randomly sampled from all state regions. We assessed presence of antibodies against SARS-CoV-2 using a validated lateral flow point-of-care test; we adjusted figures for the time-dependent decay of antibodies. Results. The SARS-CoV-2 antibody prevalence increased from 0.03% (95% confidence interval [CI] = 0.00%, 0.34%; 1 in every 3333 individuals) in mid-April to 1.89% (95% CI = 1.36%, 2.54%; 1 in every 53 individuals) in early September. Prevalence was similar across gender and skin color categories. Older adults were less likely to be infected than younger participants. The proportion of the population who reported leaving home daily increased from 21.4% (95% CI = 20.2%, 22.7%) to 33.2% (95% CI = 31.8%, 34.5%). Conclusions. SARS-CoV-2 infection increased slowly during the first 6 months in the state, differently from what was observed in other Brazilian regions. Future survey rounds will continue to document the spread of the pandemic. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
3. Population-level seropositivity trend for SARS-Cov-2 in Rio Grande do Sul, Brazil.
- Author
-
Barros AJD, Victora CG, Menezes AMB, Horta BL, Barros FC, Hartwig FP, Victora GD, Vidaletti LP, Silveira MF, Mesenburg MA, Jacques N, Struchiner CJ, Brust FR, Dall'Agnol MM, Delamare APL, François CHR, Ikeda MLR, Pellegrini DCP, Reuter CP, Silva SGD, Dellagostin OA, and Hallal PC
- Subjects
- Antibodies, Viral, Brazil epidemiology, Humans, Seroepidemiologic Studies, COVID-19, SARS-CoV-2
- Abstract
Objective: To describe the evolution of seropositivity in the State of Rio Grande do Sul, Brazil, through 10 consecutive surveys conducted between April 2020 and April 2021., Methods: Nine cities covering all regions of the State were studied, 500 households in each city. One resident in each household was randomly selected for testing. In survey rounds 1-8 we used the rapid WONDFO SARS-CoV-2 Antibody Test (Wondfo Biotech Co., Guangzhou, China). In rounds 9-10, we used a direct ELISA test that identifies IgG to the viral S protein (S-UFRJ). In terms of social distancing, individuals were asked three questions, from which we generated an exposure score using principal components analysis., Results: Antibody prevalence in early April 2020 was 0.07%, increasing to 10.0% in February 2021, and to 18.2% in April 2021. In round 10, self-reported whites showed the lowest seroprevalence (17.3%), while indigenous individuals presented the highest (44.4%). Seropositivity increased by 40% when comparing the most with the least exposed., Conclusions: The proportion of the population already infected by SARS-Cov-2 in the state is still far from any perspective of herd immunity and the infection affects population groups in very different levels.
- Published
- 2021
- Full Text
- View/download PDF
4. SARS-CoV-2 antibody prevalence in Brazil: results from two successive nationwide serological household surveys.
- Author
-
Hallal PC, Hartwig FP, Horta BL, Silveira MF, Struchiner CJ, Vidaletti LP, Neumann NA, Pellanda LC, Dellagostin OA, Burattini MN, Victora GD, Menezes AMB, Barros FC, Barros AJD, and Victora CG
- Subjects
- Adolescent, Adult, Aged, Aged, 80 and over, Brazil epidemiology, COVID-19, Child, Child, Preschool, Coronavirus Infections ethnology, Cross-Sectional Studies, Ethnicity statistics & numerical data, Family Characteristics, Female, Humans, Infant, Infant, Newborn, Male, Middle Aged, Pandemics, Pneumonia, Viral ethnology, Prevalence, SARS-CoV-2, Seroepidemiologic Studies, Social Class, Surveys and Questionnaires, Young Adult, Antibodies, Viral blood, Betacoronavirus immunology, Coronavirus Infections blood, Coronavirus Infections epidemiology, Pneumonia, Viral blood, Pneumonia, Viral epidemiology
- Abstract
Background: Population-based data on COVID-19 are essential for guiding policies. There are few such studies, particularly from low or middle-income countries. Brazil is currently a hotspot for COVID-19 globally. We aimed to investigate severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibody prevalence by city and according to sex, age, ethnicity group, and socioeconomic status, and compare seroprevalence estimates with official statistics on deaths and cases., Methods: In this repeated cross-sectional study, we did two seroprevalence surveys in 133 sentinel cities in all Brazilian states. We randomly selected households and randomly selected one individual from all household members. We excluded children younger than 1 year. Presence of antibodies against SARS-CoV-2 was assessed using a lateral flow point-of-care test, the WONDFO SARS-CoV-2 Antibody Test (Wondfo Biotech, Guangzhou, China), using two drops of blood from finger prick samples. This lateral-flow assay detects IgG and IgM isotypes that are specific to the SARS-CoV-2 receptor binding domain of the spike protein. Participants also answered short questionnaires on sociodemographic information (sex, age, education, ethnicity, household size, and household assets) and compliance with physical distancing measures., Findings: We included 25 025 participants in the first survey (May 14-21) and 31 165 in the second (June 4-7). For the 83 (62%) cities with sample sizes of more than 200 participants in both surveys, the pooled seroprevalence increased from 1·9% (95% CI 1·7-2·1) to 3·1% (2·8-3·4). City-level prevalence ranged from 0% to 25·4% in both surveys. 11 (69%) of 16 cities with prevalence above 2·0% in the first survey were located in a stretch along a 2000 km of the Amazon river in the northern region. In the second survey, we found 34 cities with prevalence above 2·0%, which included the same 11 Amazon cities plus 14 from the northeast region, where prevalence was increasing rapidly. Prevalence levels were lower in the south and centre-west, and intermediate in the southeast, where the highest level was found in Rio de Janeiro (7·5% [4·2-12·2]). In the second survey, prevalence was similar in men and women, but an increased prevalence was observed in participants aged 20-59 years and those living in crowded conditions (4·4% [3·5-5·6] for those living with households with six or more people). Prevalence among Indigenous people was 6·4% (4·1-9·4) compared with 1·4% (1·2-1·7) among White people. Prevalence in the poorest socioeconomic quintile was 3·7% (3·2-4·3) compared with 1·7% (1·4-2·2) in the wealthiest quintile., Interpretation: Antibody prevalence was highly heterogeneous by country region, with rapid initial escalation in Brazil's north and northeast. Prevalence is strongly associated with Indigenous ancestry and low socioeconomic status. These population subgroups are unlikely to be protected if the policy response to the pandemic by the national government continues to downplay scientific evidence., Funding: Brazilian Ministry of Health, Instituto Serrapilheira, Brazilian Collective Health Association, and the JBS Fazer o Bem Faz Bem., (Copyright © 2020 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. Published by Elsevier Ltd.. All rights reserved.)
- Published
- 2020
- Full Text
- View/download PDF
5. Population-based surveys of antibodies against SARS-CoV-2 in Southern Brazil.
- Author
-
Silveira MF, Barros AJD, Horta BL, Pellanda LC, Victora GD, Dellagostin OA, Struchiner CJ, Burattini MN, Valim ARM, Berlezi EM, Mesa JM, Ikeda MLR, Mesenburg MA, Mantesso M, Dall'Agnol MM, Bittencourt RA, Hartwig FP, Menezes AMB, Barros FC, Hallal PC, and Victora CG
- Subjects
- Adolescent, Adult, Aged, Aged, 80 and over, Antibodies, Viral immunology, Betacoronavirus immunology, Betacoronavirus pathogenicity, Brazil epidemiology, COVID-19, Child, Child, Preschool, Coronavirus Infections immunology, Female, Humans, Immunoglobulin M immunology, Infant, Male, Middle Aged, Pandemics, Pneumonia, Viral immunology, SARS-CoV-2, Seroepidemiologic Studies, Young Adult, Antibodies, Viral blood, Coronavirus Infections blood, Coronavirus Infections epidemiology, Immunoglobulin M blood, Pneumonia, Viral blood, Pneumonia, Viral epidemiology
- Abstract
Population-based data on COVID-19 are urgently needed. We report on three rounds of probability sample household surveys in the state of Rio Grande do Sul (Brazil), carried out in nine large municipalities using the Wondfo lateral flow point-of-care test for immunoglobulin M and G antibodies against SARS-CoV-2 (https://en.wondfo.com.cn/product/wondfo-sars-cov-2-antibody-test-lateral-flow-method-2/). Before survey use, the assay underwent four validation studies with pooled estimates of sensitivity (84.8%; 95% confidence interval (CI) = 81.4-87.8%) and specificity (99.0%; 95% CI = 97.8-99.7%). We calculated that the seroprevalence was 0.048% (2/4,151; 95% CI = 0.006-0.174) on 11-13 April (round 1), 0.135% (6/4,460; 95% CI = 0.049-0.293%) on 25-27 April (round 2) and 0.222% (10/4,500; 95% CI = 0.107-0.408) on 9-11 May (round 3), with a significant upward trend over the course of the surveys. Of 37 family members of positive individuals, 17 (35%) were also positive. The epidemic is at an early stage in the state, and there is high compliance with social distancing, unlike in other parts of Brazil. Periodic survey rounds will continue to monitor trends until at least the end of September, and our population-based data will inform decisions on preventive policies and health system preparedness at the state level.
- Published
- 2020
- Full Text
- View/download PDF
6. Mother-child immunological interactions in early life affect long-term humoral autoreactivity to heat shock protein 60 at age 18 years.
- Author
-
Victora GD, Bilate AM, Socorro-Silva A, Caldas C, Lima RC, Kalil J, Coelho V, and Victora CG
- Subjects
- Adolescent, Birth Weight, Brazil, Breast Feeding, Child, Female, Humans, Male, Pregnancy, Autoantibodies blood, Chaperonin 60 immunology, Immunoglobulin G blood, Maternal-Fetal Exchange
- Abstract
The presence of anti-heat shock protein 60 (Hsp60) antibodies in healthy individuals and the association of these antibodies with diseases such as arthritis and atherosclerosis are well documented. However, there is limited population-level data on interindividual variation in anti-Hsp60 levels. We investigated the influence of early-life factors on IgG reactivity to human Hsp60 at age 18 years. A population-based prospective birth cohort study included 5914 births in the city of Pelotas, Brazil, in 1982. Early-life exposures were documented during home visits in childhood. In 2000, 79% of all males in the cohort were traced. Sera from a systematic 20% sample (411 subjects) were analyzed. Anti-Hsp60 total IgG reactivity was determined by ELISA. Data were analyzed using analysis of variance and generalized linear models. Anti-Hsp60 reactivity was lognormally distributed and showed a significant direct correlation with low birthweight (p=0.039) and total duration of breastfeeding (p=0.018), of which only the latter remained significant after adjustment for potential confounders. Reactivity was not associated with asthma, pneumonia, diarrhea, or early-life malnutrition. Mother-child immunological interactions, rather than infection/disease factors seem to be associated with reactivity to Hsp60 later in life. This is in agreement with the hypothesis that maternal antibodies influence future antibody profile.
- Published
- 2007
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.